Argus Research has issued a BUY recommendation for Salesforce Incorporated (NYSE: CRM), highlighting its strategic focus on profitability, innovation, and operational excellence.

Morningstar Equity Research has reaffirmed its fair value estimate of $290 per share for Salesforce (CRM).